BCH Misses Earnings Again—Why Analysts Stay Bullish

Generated by AI AgentAinvest Crypto Movers RadarReviewed byTianhao Xu
Wednesday, Mar 25, 2026 2:11 am ET1min read
Aime RobotAime Summary

- Bangkok Chain Hospital PCL (BCH) has repeatedly missed earnings forecasts, with December 2025 EPS at 0.10 THB vs. 0.14 THB expected.

- Analysts maintain a "Buy" rating (e.g., CLSA at 16 THB) despite consistent revenue shortfalls and a 9.65% stock price drop following recent reports.

- Market reactions show mixed signals: a 20.4% decline since March 2025 contrasts with 4.28% monthly gains, reflecting short-term resilience amid long-term challenges.

- Persistent earnings gaps highlight the need for stronger performance to align with analyst optimism and restore investor confidence.

Earnings Performance Lags Behind Forecasts

Bangkok Chain Hospital PCL (BCH) has seen a series of earnings results that consistently fell short of expectations over the past 15 months. The most recent quarterly report for December 2025 showed an EPS of 0.10 THB against a forecast of 0.14 THB, representing a 28.57% earnings surprise deficit. This decline was accompanied by a revenue shortfall of 2.62%, with actual revenue at 2.97 billion THB versus an expected 3.05 billion THB. The report also coincided with a price drop of 9.65%.

This pattern of underperformance has repeated across previous quarters. For example, in the September 2025 report, EPS came in at 0.14 THB versus 0.17 THB expected, reflecting a 17.65% earnings surprise shortfall, while revenue declined by 6.48%. The trend continued into the June 2025 period, with a narrower earnings surprise but still an unexpected 14.29% increase in EPS.

Analysts Maintain Bullish Outlook Despite Weak Results

Despite the earnings underperformance, analysts have maintained a generally positive stance toward the stock. CLSA, for instance, reiterated a “Buy” recommendation with a price target of 16 THB as of May 28, 2025. This implies a potential upside of 68.42% from that time, based on its target. While the recommendation has not been updated since, it reflects the broader confidence in the company’s longer-term trajectory.

The earnings releases and subsequent market reactions suggest a consistent disconnect between the company’s operating results and analyst sentiment. For example, in the September 2024 quarter, earnings fell slightly short of forecasts by 2.70%, and revenue also missed by a narrow margin, yet the stock still gained 1.86% in price.

Market Reaction Reflects Mixed Signals

The stock’s price movement over the last year has been volatile, with a 20.4% drop since March 25, 2025. However, this longer-term decline is contrasted with more recent stability. Over the past week, BCH rose by 0.55%, and over the past month, it gained 4.28%. These figures suggest that while the long-term outlook remains challenged, the market has shown some short-term resilience.

The price has currently dipped 0.04% in the last 24 hours, indicating a cautious stance among traders in the immediate term. This slight decline is in line with the broader earnings performance trend, where expectations have consistently exceeded actual results.

Conclusion

Bangkok Chain Hospital PCL (BCH) continues to face pressure from earnings results that have consistently missed forecasts, despite a stable price over the short term. Analysts remain bullish in their outlook, with CLSA maintaining a “Buy” recommendation. However, the market’s reaction to recent earnings suggests that the company must demonstrate stronger performance to align with expectations and restore investor confidence.

Delivering real-time analysis and insights on unexpected cryptocurrency price movements to keep traders ahead of the curve.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet